BorgWarner (NYSE: BWA) proposes sale of 12,012 compensation shares via Form 144

Rhea-AI Filing Summary

BorgWarner Inc. submitted a Form 144 notice proposing the sale of equity awards tied to compensation. The filing lists 7,000 shares associated with a Performance Stock Lapse dated 02/04/2026 and 5,012 shares associated with a Restricted Stock Lapse dated 02/28/2026.

The entries are labeled as Equity Compensation and reference common stock; timing and proceeds treatment beyond the dates shown are not detailed in the excerpt.

Insights

Corporate Governance Analyst

Form 144 lists proposed sales of compensation-derived shares totaling 12,012 shares.

The filing shows 7,000 shares from a Performance Stock Lapse (dated 02/04/2026) and 5,012 shares from a Restricted Stock Lapse (dated 02/28/2026), each labeled Equity Compensation. The record ties the entries to Common stock.

Cash‑flow treatment and sale mechanics are not provided in the excerpt; subsequent SEC filings or transaction confirmations would state whether sales occurred and under what methods.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	12012	628321.00	207048768	03/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/04/2026	Performance Stock Lapse	BORG WARNER INC			7000	02/04/2026	Equity Compensation
Common	02/28/2026	Restricted Stock Lapse	BORG WARNER INC			5012	02/28/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does BorgWarner's Form 144 (BWA) disclose?

The Form 144 discloses proposed sales of equity compensation totaling 12,012 shares. It lists 7,000 shares from a Performance Stock Lapse (02/04/2026) and 5,012 shares from a Restricted Stock Lapse (02/28/2026).

Are the shares tied to compensation or open‑market purchases in the BWA filing?

The excerpt labels both entries as Equity Compensation. One entry is a Performance Stock Lapse and the other a Restricted Stock Lapse, indicating the shares originate from compensation awards.

Does the Form 144 state how BorgWarner will sell the shares?

The provided content does not specify sale mechanics or methods. The excerpt shows dates and share counts but does not include brokerage, block trade, or other distribution details.

What dates are associated with the proposed sales in the BWA Form 144?

The filing shows two dates tied to the listed securities: 02/04/2026 for the Performance Stock Lapse and 02/28/2026 for the Restricted Stock Lapse, each paired with its share count.

Do the entries in the Form 144 indicate proceeds or destination of sale proceeds?

The excerpt does not state proceeds amounts or beneficiaries. It only lists the security type, lapse description, dates, and share counts; proceeds treatment is not included in the content.